A retrospective, observational study analyzing the retention of cenobamate in a nationally representative administrative claims database
Latest Information Update: 27 Jan 2023
At a glance
- Drugs Cenobamate (Primary) ; Brivaracetam; Eslicarbazepine acetate; Lacosamide; Perampanel
- Indications Seizures
- Focus Therapeutic Use
Most Recent Events
- 27 Jan 2023 New trial record
- 06 Dec 2022 Results presented at the 76th Annual Meeting of the American Epilepsy Society